Loading…
Penicillin and Spectinomycin in Treatment of Gonococcal Urethritis
In view of the recent discovery of penicillinase-producing strains of Neisseria gonorrhoeae in Zambia, the efficacies of single intramuscular doses of aqueous procaine penicillin G (4.8 × 10⁶ units plus 1 g of oral probenecid) and 2 g of spectinomycin were evaluated in an open clinical trial of the...
Saved in:
Published in: | Sexually transmitted diseases 1982-07, Vol.9 (3), p.135-137 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c382t-3a09985819c24d6dd2d5b05f9aa0a7bb9741b72d954931bb4edb811305097b573 |
---|---|
cites | |
container_end_page | 137 |
container_issue | 3 |
container_start_page | 135 |
container_title | Sexually transmitted diseases |
container_volume | 9 |
creator | RATNAM, ATTILI V. PATEL, MOHMEDALI I. HIRA, SUBHASH K. MULENGA, RAPHAEL C. |
description | In view of the recent discovery of penicillinase-producing strains of Neisseria gonorrhoeae in Zambia, the efficacies of single intramuscular doses of aqueous procaine penicillin G (4.8 × 10⁶ units plus 1 g of oral probenecid) and 2 g of spectinomycin were evaluated in an open clinical trial of the treatment of acute gonococcal urethritis in men. The former regimen was given to 123 men; failure of treatment was observed in 9.1% of the 88 men followed for two weeks. Spectinomycin was given to 124 men; treatment failure occurred in 3.8% of the 104 men followed for two weeks. During the trial, 190 unselected isolates of N. gonorrhoeae were screened by rapid iodometric test, and two penicillinase-producing strains were detected. MICs of penicillin and spectinomycin were determined by the agar dilution method for 110 and 98 isolates, respectively. MICs of penicillin of ⩾0.125 μg/ml were observed with 78.2% of the strains, while 83.7% had MICs of spectinomycin of ⩽15.0 μg/ml. It was suggested that penicillin be given routinely for treatment of gonorrhea in Zambia and that spectinomycin be reserved for treatment of gonococcal infections not cured by penicillin. |
doi_str_mv | 10.1097/00007435-198207000-00007 |
format | article |
fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_80203247</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>44965811</jstor_id><sourcerecordid>44965811</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-3a09985819c24d6dd2d5b05f9aa0a7bb9741b72d954931bb4edb811305097b573</originalsourceid><addsrcrecordid>eNpFUNtKAzEQDaLUWv0EYZ98W811kzxq0SoUFGyfl9wWU3Y3NUkf-vfu2lqHgWHOzJnLAaBA8B5ByR_gYJwSViIpMORDVv5CZ2CKGOElZRidgylEVJSMI34JrlLawDGHaAImFUZVhfAUPH243hvftr4vVG-Lz60z2feh25sBGXwVncqd63MRmmIR-mCCMaot1tHlr-izT9fgolFtcjfHOAPrl-fV_LVcvi_e5o_L0hCBc0kUlFIwgaTB1FbWYss0ZI1UCiquteQUaY6tZFQSpDV1VguECGTDw5pxMgN3h7nbGL53LuW688m4tlW9C7tUC4ghwXRsFIdGE0NK0TX1NvpOxX2NYD3KV__JV5_kO0AD9fa4Y6c7Z0_Eo17_9U3KIZ7KlMqKjcf-ANNYc2I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80203247</pqid></control><display><type>article</type><title>Penicillin and Spectinomycin in Treatment of Gonococcal Urethritis</title><source>JSTOR Archival Journals and Primary Sources Collection</source><creator>RATNAM, ATTILI V. ; PATEL, MOHMEDALI I. ; HIRA, SUBHASH K. ; MULENGA, RAPHAEL C.</creator><creatorcontrib>RATNAM, ATTILI V. ; PATEL, MOHMEDALI I. ; HIRA, SUBHASH K. ; MULENGA, RAPHAEL C.</creatorcontrib><description>In view of the recent discovery of penicillinase-producing strains of Neisseria gonorrhoeae in Zambia, the efficacies of single intramuscular doses of aqueous procaine penicillin G (4.8 × 10⁶ units plus 1 g of oral probenecid) and 2 g of spectinomycin were evaluated in an open clinical trial of the treatment of acute gonococcal urethritis in men. The former regimen was given to 123 men; failure of treatment was observed in 9.1% of the 88 men followed for two weeks. Spectinomycin was given to 124 men; treatment failure occurred in 3.8% of the 104 men followed for two weeks. During the trial, 190 unselected isolates of N. gonorrhoeae were screened by rapid iodometric test, and two penicillinase-producing strains were detected. MICs of penicillin and spectinomycin were determined by the agar dilution method for 110 and 98 isolates, respectively. MICs of penicillin of ⩾0.125 μg/ml were observed with 78.2% of the strains, while 83.7% had MICs of spectinomycin of ⩽15.0 μg/ml. It was suggested that penicillin be given routinely for treatment of gonorrhea in Zambia and that spectinomycin be reserved for treatment of gonococcal infections not cured by penicillin.</description><identifier>ISSN: 0148-5717</identifier><identifier>EISSN: 1537-4521</identifier><identifier>DOI: 10.1097/00007435-198207000-00007</identifier><identifier>PMID: 6216612</identifier><language>eng</language><publisher>United States: J. B. Lippincott Company</publisher><subject>Acute Disease ; Clinical Trials as Topic ; Drug Therapy, Combination ; Gonorrhea - complications ; Gonorrhea - drug therapy ; Gonorrhea - epidemiology ; Humans ; Male ; Neisseria gonorrhoeae - isolation & purification ; Neisseria gonorrhoeae - metabolism ; Penicillin G Procaine - administration & dosage ; Penicillin G Procaine - therapeutic use ; Penicillinase - biosynthesis ; Probenecid - administration & dosage ; Probenecid - therapeutic use ; Spectinomycin - administration & dosage ; Spectinomycin - therapeutic use ; Urethritis - drug therapy ; Urethritis - etiology ; Urethritis - microbiology ; Zambia</subject><ispartof>Sexually transmitted diseases, 1982-07, Vol.9 (3), p.135-137</ispartof><rights>Copyright 1982 American Venereal Disease Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c382t-3a09985819c24d6dd2d5b05f9aa0a7bb9741b72d954931bb4edb811305097b573</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/44965811$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/44965811$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,58238,58471</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6216612$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>RATNAM, ATTILI V.</creatorcontrib><creatorcontrib>PATEL, MOHMEDALI I.</creatorcontrib><creatorcontrib>HIRA, SUBHASH K.</creatorcontrib><creatorcontrib>MULENGA, RAPHAEL C.</creatorcontrib><title>Penicillin and Spectinomycin in Treatment of Gonococcal Urethritis</title><title>Sexually transmitted diseases</title><addtitle>Sex Transm Dis</addtitle><description>In view of the recent discovery of penicillinase-producing strains of Neisseria gonorrhoeae in Zambia, the efficacies of single intramuscular doses of aqueous procaine penicillin G (4.8 × 10⁶ units plus 1 g of oral probenecid) and 2 g of spectinomycin were evaluated in an open clinical trial of the treatment of acute gonococcal urethritis in men. The former regimen was given to 123 men; failure of treatment was observed in 9.1% of the 88 men followed for two weeks. Spectinomycin was given to 124 men; treatment failure occurred in 3.8% of the 104 men followed for two weeks. During the trial, 190 unselected isolates of N. gonorrhoeae were screened by rapid iodometric test, and two penicillinase-producing strains were detected. MICs of penicillin and spectinomycin were determined by the agar dilution method for 110 and 98 isolates, respectively. MICs of penicillin of ⩾0.125 μg/ml were observed with 78.2% of the strains, while 83.7% had MICs of spectinomycin of ⩽15.0 μg/ml. It was suggested that penicillin be given routinely for treatment of gonorrhea in Zambia and that spectinomycin be reserved for treatment of gonococcal infections not cured by penicillin.</description><subject>Acute Disease</subject><subject>Clinical Trials as Topic</subject><subject>Drug Therapy, Combination</subject><subject>Gonorrhea - complications</subject><subject>Gonorrhea - drug therapy</subject><subject>Gonorrhea - epidemiology</subject><subject>Humans</subject><subject>Male</subject><subject>Neisseria gonorrhoeae - isolation & purification</subject><subject>Neisseria gonorrhoeae - metabolism</subject><subject>Penicillin G Procaine - administration & dosage</subject><subject>Penicillin G Procaine - therapeutic use</subject><subject>Penicillinase - biosynthesis</subject><subject>Probenecid - administration & dosage</subject><subject>Probenecid - therapeutic use</subject><subject>Spectinomycin - administration & dosage</subject><subject>Spectinomycin - therapeutic use</subject><subject>Urethritis - drug therapy</subject><subject>Urethritis - etiology</subject><subject>Urethritis - microbiology</subject><subject>Zambia</subject><issn>0148-5717</issn><issn>1537-4521</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1982</creationdate><recordtype>article</recordtype><recordid>eNpFUNtKAzEQDaLUWv0EYZ98W811kzxq0SoUFGyfl9wWU3Y3NUkf-vfu2lqHgWHOzJnLAaBA8B5ByR_gYJwSViIpMORDVv5CZ2CKGOElZRidgylEVJSMI34JrlLawDGHaAImFUZVhfAUPH243hvftr4vVG-Lz60z2feh25sBGXwVncqd63MRmmIR-mCCMaot1tHlr-izT9fgolFtcjfHOAPrl-fV_LVcvi_e5o_L0hCBc0kUlFIwgaTB1FbWYss0ZI1UCiquteQUaY6tZFQSpDV1VguECGTDw5pxMgN3h7nbGL53LuW688m4tlW9C7tUC4ghwXRsFIdGE0NK0TX1NvpOxX2NYD3KV__JV5_kO0AD9fa4Y6c7Z0_Eo17_9U3KIZ7KlMqKjcf-ANNYc2I</recordid><startdate>198207</startdate><enddate>198207</enddate><creator>RATNAM, ATTILI V.</creator><creator>PATEL, MOHMEDALI I.</creator><creator>HIRA, SUBHASH K.</creator><creator>MULENGA, RAPHAEL C.</creator><general>J. B. Lippincott Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198207</creationdate><title>Penicillin and Spectinomycin in Treatment of Gonococcal Urethritis</title><author>RATNAM, ATTILI V. ; PATEL, MOHMEDALI I. ; HIRA, SUBHASH K. ; MULENGA, RAPHAEL C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-3a09985819c24d6dd2d5b05f9aa0a7bb9741b72d954931bb4edb811305097b573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1982</creationdate><topic>Acute Disease</topic><topic>Clinical Trials as Topic</topic><topic>Drug Therapy, Combination</topic><topic>Gonorrhea - complications</topic><topic>Gonorrhea - drug therapy</topic><topic>Gonorrhea - epidemiology</topic><topic>Humans</topic><topic>Male</topic><topic>Neisseria gonorrhoeae - isolation & purification</topic><topic>Neisseria gonorrhoeae - metabolism</topic><topic>Penicillin G Procaine - administration & dosage</topic><topic>Penicillin G Procaine - therapeutic use</topic><topic>Penicillinase - biosynthesis</topic><topic>Probenecid - administration & dosage</topic><topic>Probenecid - therapeutic use</topic><topic>Spectinomycin - administration & dosage</topic><topic>Spectinomycin - therapeutic use</topic><topic>Urethritis - drug therapy</topic><topic>Urethritis - etiology</topic><topic>Urethritis - microbiology</topic><topic>Zambia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>RATNAM, ATTILI V.</creatorcontrib><creatorcontrib>PATEL, MOHMEDALI I.</creatorcontrib><creatorcontrib>HIRA, SUBHASH K.</creatorcontrib><creatorcontrib>MULENGA, RAPHAEL C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Sexually transmitted diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>RATNAM, ATTILI V.</au><au>PATEL, MOHMEDALI I.</au><au>HIRA, SUBHASH K.</au><au>MULENGA, RAPHAEL C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Penicillin and Spectinomycin in Treatment of Gonococcal Urethritis</atitle><jtitle>Sexually transmitted diseases</jtitle><addtitle>Sex Transm Dis</addtitle><date>1982-07</date><risdate>1982</risdate><volume>9</volume><issue>3</issue><spage>135</spage><epage>137</epage><pages>135-137</pages><issn>0148-5717</issn><eissn>1537-4521</eissn><abstract>In view of the recent discovery of penicillinase-producing strains of Neisseria gonorrhoeae in Zambia, the efficacies of single intramuscular doses of aqueous procaine penicillin G (4.8 × 10⁶ units plus 1 g of oral probenecid) and 2 g of spectinomycin were evaluated in an open clinical trial of the treatment of acute gonococcal urethritis in men. The former regimen was given to 123 men; failure of treatment was observed in 9.1% of the 88 men followed for two weeks. Spectinomycin was given to 124 men; treatment failure occurred in 3.8% of the 104 men followed for two weeks. During the trial, 190 unselected isolates of N. gonorrhoeae were screened by rapid iodometric test, and two penicillinase-producing strains were detected. MICs of penicillin and spectinomycin were determined by the agar dilution method for 110 and 98 isolates, respectively. MICs of penicillin of ⩾0.125 μg/ml were observed with 78.2% of the strains, while 83.7% had MICs of spectinomycin of ⩽15.0 μg/ml. It was suggested that penicillin be given routinely for treatment of gonorrhea in Zambia and that spectinomycin be reserved for treatment of gonococcal infections not cured by penicillin.</abstract><cop>United States</cop><pub>J. B. Lippincott Company</pub><pmid>6216612</pmid><doi>10.1097/00007435-198207000-00007</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0148-5717 |
ispartof | Sexually transmitted diseases, 1982-07, Vol.9 (3), p.135-137 |
issn | 0148-5717 1537-4521 |
language | eng |
recordid | cdi_proquest_miscellaneous_80203247 |
source | JSTOR Archival Journals and Primary Sources Collection |
subjects | Acute Disease Clinical Trials as Topic Drug Therapy, Combination Gonorrhea - complications Gonorrhea - drug therapy Gonorrhea - epidemiology Humans Male Neisseria gonorrhoeae - isolation & purification Neisseria gonorrhoeae - metabolism Penicillin G Procaine - administration & dosage Penicillin G Procaine - therapeutic use Penicillinase - biosynthesis Probenecid - administration & dosage Probenecid - therapeutic use Spectinomycin - administration & dosage Spectinomycin - therapeutic use Urethritis - drug therapy Urethritis - etiology Urethritis - microbiology Zambia |
title | Penicillin and Spectinomycin in Treatment of Gonococcal Urethritis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T01%3A24%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Penicillin%20and%20Spectinomycin%20in%20Treatment%20of%20Gonococcal%20Urethritis&rft.jtitle=Sexually%20transmitted%20diseases&rft.au=RATNAM,%20ATTILI%20V.&rft.date=1982-07&rft.volume=9&rft.issue=3&rft.spage=135&rft.epage=137&rft.pages=135-137&rft.issn=0148-5717&rft.eissn=1537-4521&rft_id=info:doi/10.1097/00007435-198207000-00007&rft_dat=%3Cjstor_proqu%3E44965811%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c382t-3a09985819c24d6dd2d5b05f9aa0a7bb9741b72d954931bb4edb811305097b573%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=80203247&rft_id=info:pmid/6216612&rft_jstor_id=44965811&rfr_iscdi=true |